Quick Answer
Silo Pharma, Inc. reported Total Assets of $7.61 million for the year ending 2025.
- Silo Pharma, Inc. showed an increase of +2.6% in Total Assets from 2024 to 2025.
- This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $25.8 thousand | Q3 2011: $4.6 thousand | Q1 2012: $3.7 thousand | Q2 2012: $813.00 | Q3 2012: $279.00 | Q1 2013: $10.1 thousand | Q2 2013: $368.7 thousand | Q3 2013: $1.26 million | Q3 2018: $1.44 million | Q1 2019: $750.9 thousand | Q2 2019: $535.5 thousand | Q3 2019: $386.5 thousand | Q1 2020: $403.8 thousand | Q2 2020: $2.80 million | Q3 2020: $2.20 million | Q1 2021: $5.50 million | Q2 2021: $5.00 million | Q3 2021: $11.39 million | Q1 2022: $9.72 million | Q2 2022: $9.04 million | Q3 2022: $13.05 million | Q1 2023: $11.02 million | Q2 2023: $10.25 million | Q3 2023: $8.99 million | Q1 2024: $6.94 million | Q2 2024: $8.04 million | Q3 2024: $8.57 million | Q1 2025: $5.90 million | Q2 2025: $6.65 million | Q3 2025: $6.38 million.
- Over the full 13 years of available data (2010 to 2025), Silo Pharma, Inc.'s Total Assets has grown by 15,917.5%.
- Historical annual values: Fiscal year 2025: $7.61 million | Fiscal year 2024: $7.41 million | Fiscal year 2023: $7.75 million | Fiscal year 2022: $11.64 million | Fiscal year 2021: $10.49 million | Fiscal year 2020: $1.43 million | Fiscal year 2019: $493.8 thousand | Fiscal year 2018: $855.4 thousand | Fiscal year 2017: $1.64 million | Fiscal year 2013: $2.21 million | Fiscal year 2012: $279.00 | Fiscal year 2011: $1.8 thousand | Fiscal year 2010: $47.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: